Patents by Inventor Nancy Harrison
Nancy Harrison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230226015Abstract: This invention relates to novel products of compressed Cannabis flower for medicinal and/or recreational use, and for methods of making such products.Type: ApplicationFiled: March 7, 2023Publication date: July 20, 2023Inventors: Christopher Wagner, Nancy Harrison, Freydoun Garabagi
-
Publication number: 20220354821Abstract: This invention relates to novel products of Cannabis flower for medicinal and/or recreational use, and for methods of making such products.Type: ApplicationFiled: January 27, 2022Publication date: November 10, 2022Inventors: Christopher WAGNER, Nancy HARRISON
-
Publication number: 20210000789Abstract: Cannabis pods comprising a defined dose of Cannabis and methods for making said pods. This method comprises milling or grinding the Cannabis, passing it through a mesh or sieve, determining the desired amount of cannabinoid, and encapsulating the Cannabis dose in a textile.Type: ApplicationFiled: March 18, 2019Publication date: January 7, 2021Inventors: Christopher WAGNER, Nancy HARRISON
-
Publication number: 20200405686Abstract: This invention relates to novel products of compressed Cannabis flower for medicinal and/or recreational use, and for methods of making such products.Type: ApplicationFiled: March 18, 2019Publication date: December 31, 2020Inventors: Christopher WAGNER, Nancy HARRISON, Freydoun GARABAGI
-
Publication number: 20190060345Abstract: Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved pharmacokinetic profiles. More specifically, the invention is directed to methods of treating a disease or disorder in a subject and/or improving the nutritional status of a subject by administering formulations exhibiting improved pharmacokinetic profiles of exogenous SAMe. The method also includes the step of orally administering compositions of the invention to the subject once per day after overnight fast; that is prior to food intake in the morning.Type: ApplicationFiled: February 22, 2018Publication date: February 28, 2019Inventors: Nancy HARRISON, I. David MACDONALD, Aniko TAKACS-COX, Robert MILLER
-
Patent number: 9931356Abstract: Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved pharmacokinetic profiles. More specifically, the invention is directed to methods of treating a disease or disorder in a subject and/or improving the nutritional status of a subject by administering formulations exhibiting improved pharmacokinetic profiles of exogenous SAMe. The method also includes the step of orally administering compositions of the invention to the subject once per day after overnight fast; that is prior to food intake in the morning.Type: GrantFiled: August 23, 2016Date of Patent: April 3, 2018Assignee: METHYLATION SCIENCES INTERNATIONAL SRLInventors: Nancy Harrison, I. David MacDonald, Aniko Takacs-Cox, Robert Miller
-
Publication number: 20160361339Abstract: Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved pharmacokinetic profiles. More specifically, the invention is directed to methods of treating a disease or disorder in a subject and/or improving the nutritional status of a subject by administering formulations exhibiting improved pharmacokinetic profiles of exogenous SAMe. The method also includes the step of orally administering compositions of the invention to the subject once per day after overnight fast; that is prior to food intake in the morning.Type: ApplicationFiled: August 23, 2016Publication date: December 15, 2016Inventors: Nancy HARRISON, I. David MACDONALD, Aniko TAKACS-COX, Robert MILLER
-
Publication number: 20140370108Abstract: Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved pharmacokinetic profiles. More specifically, the invention is directed to methods of treating a disease or disorder in a subject and/or improving the nutritional status of a subject by administering formulations exhibiting improved pharmacokinetic profiles of exogenous SAMe. The method also includes the step of orally administering compositions of the invention to the subject once per day after overnight fast; that is prior to food intake in the morning.Type: ApplicationFiled: August 28, 2014Publication date: December 18, 2014Inventors: Nancy HARRISON, I. David MacDonald, Aniko Takacs-Cox, Robert Miller
-
Patent number: 8865203Abstract: Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved pharmacokinetic profiles. More specifically, the invention is directed to methods of treating a disease or disorder in a subject and/or improving the nutritional status of a subject by administering formulations exhibiting improved pharmacokinetic profiles of exogenous SAMe. The method also includes the step of orally administering compositions of the invention to the subject once per day after overnight fast; that is prior to food intake in the morning.Type: GrantFiled: December 5, 2012Date of Patent: October 21, 2014Assignee: Methylation Sciences International SRLInventors: Nancy Harrison, I. David MacDonald, Aniko Takacs-Cox, Robert Miller
-
Patent number: 8580296Abstract: Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved pharmacokinetic profiles. More specifically, the invention is directed to methods of treating a disease or disorder in a subject and/or improving the nutritional status of a subject by administering formulations exhibiting improved pharmacokinetic profiles of exogenous SAMe. The method also includes the step of orally administering compositions of the invention to the subject once per day after overnight fast; that is prior to food intake in the morning.Type: GrantFiled: December 13, 2012Date of Patent: November 12, 2013Assignee: Methylation Sciences International SRLInventors: Nancy Harrison, I. David MacDonald, Aniko Takacs-Cox, Robert Miller
-
Patent number: 8551515Abstract: Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved pharmacokinetic profiles. More specifically, the invention is directed to methods of treating a disease or disorder in a subject and/or improving the nutritional status of a subject by administering formulations exhibiting improved pharmacokinetic profiles of exogenous SAMe. The method also includes the step of orally administering compositions of the invention to the subject once per day after overnight fast; that is prior to food intake in the morning.Type: GrantFiled: December 13, 2012Date of Patent: October 8, 2013Assignee: Methylation Sciences International SRLInventors: Nancy Harrison, I. David MacDonald, Aniko Takacs-Cox, Robert Miller
-
Publication number: 20130142847Abstract: Provided herein are compositions and methods to enhance the absorption of S-adenosylmethionine (SAMe) and methods of treating various disorders or diseases using non-parenteral SAMe formulations with enhanced-absorption and improved bioavailability. In certain embodiments, the enhanced bioavailability formulations provided herein may be used to treat a variety of diseases or disorders, such as for example, psychiatric disorders including, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, depressive disorders (e.g. major clinical depression) and dysthymia; as well as treating liver disorders, cancer, autoimmune disorders, inflammatory disorders, joint disorders, gastrointestinal disorders and cardiovascular disease.Type: ApplicationFiled: July 27, 2011Publication date: June 6, 2013Applicant: Methylation Sciences, Inc.Inventors: I. David MacDonald, Nancy Harrison, Aniko Takacs-Cox, Admir Purac, Almira Blazek-Welsh
-
Patent number: 8329208Abstract: Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved pharmacokinetic profiles. More specifically, the invention is directed to methods of treating a disease or disorder in a subject and/or improving the nutritional status of a subject by administering formulations exhibiting improved pharmacokinetic profiles of exogenous SAMe. The method also includes the step of orally administering compositions of the invention to the subject once per day after overnight fast; that is prior to food intake in the morning.Type: GrantFiled: July 28, 2010Date of Patent: December 11, 2012Assignee: Methylation Sciences International SRLInventors: Nancy Harrison, I. David MacDonald, Aniko Takacs-Cox, Robert Miller
-
Publication number: 20110027360Abstract: Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved pharmacokinetic profiles. More specifically, the invention is directed to methods of treating a disease or disorder in a subject and/or improving the nutritional status of a subject by administering formulations exhibiting improved pharmacokinetic profiles of exogenous SAMe. The method also includes the step of orally administering compositions of the invention to the subject once per day after overnight fast; that is prior to food intake in the morning.Type: ApplicationFiled: July 28, 2010Publication date: February 3, 2011Applicant: METHYLATION SCIENCES INTERNATIONAL SRLInventors: Nancy Harrison, I. David MacDonald, Aniko Takacs-Cox, Robert Miller
-
Publication number: 20110027342Abstract: The invention relates to compositions and methods to enhance the absorption of S-adenosylmethionine (SAMe) and to methods of treating various disorders or diseases using non-parenteral SAMe formulations with enhanced-absorption and improved bioavailability. The enhanced bioavailability formulations may be used to treat a variety of diseases or disorders, such as for example, psychiatric disorders including, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, depressive disorders (e.g. major clinical depression) and dysthymia; as well as treating liver disorders, cancer, autoimmune disorders, inflammatory disorders, joint disorders, gastrointestinal disorders and cardiovascular disease.Type: ApplicationFiled: July 28, 2010Publication date: February 3, 2011Applicant: MSI METHYLATION SCIENCES, INC.Inventors: I. David MacDonald, Nancy Harrison, Aniko Takacs-Cox, Admir Purac, Almira Blazek-Welsh
-
Publication number: 20090197824Abstract: Extended release formulations of S-methyladenosylmethionine (SAMe) are provided, as are methods of treating various disorders using extended release SAMe formulations. The extended release formulations may be used to treat a variety of disorders, including liver disorders, psychiatric disorders and joint disorders. Thus, extended release SAMe formulations may be used to treat alcoholic liver disease, fatty liver disease, hepatitis, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, and depressive disorders such as depression (e.g. major clinical depression) and dysthymia.Type: ApplicationFiled: July 17, 2008Publication date: August 6, 2009Applicant: METHYLATION SCIENCES INTERNATIONAL SRLInventors: Joshua Freedman, Aviva Revgev, Nancy Harrison, Robert Miller, David MacDonald
-
Publication number: 20090088404Abstract: Extended release formulations of S-methyladenosylmethionine (SAMe) are provided, as are methods of treating various disorders using extended release SAMe formulations. The extended release formulations may be used to treat a variety of disorders, including liver disorders, psychiatric disorders and joint disorders. Thus, extended release SAMe formulations may be used to treat alcoholic liver disease, fatty liver disease, hepatitis, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, and depressive disorders such as depression (e.g. major clinical depression) and dysthymia.Type: ApplicationFiled: July 29, 2008Publication date: April 2, 2009Applicant: Methylation Sciences International SRLInventors: Joshua Freedman, Aviva Regev, Nancy Harrison, Robert Miller, David MacDonald